REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jm Sante Sp. z o.o. sp. k. (Poland)

Main Activities: Dog and Cat Food Manufacturing
Full name: Jm Sante Sp. z o.o. sp. k. Profile Updated: September 30, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

JM Sante is a Polish company that specializes in animal pharmaceutical preparations. The company offers a range of animal pharmaceutical preparations.

Headquarters
Ul. Jozefa Pilsudskiego 11
Konstancin-Jeziorna; Mazowieckie; Postal Code: 05-510

Contact Details: Purchase the Jm Sante Sp. z o.o. sp. k. report to view the information.

Website: http://www.jmsante.pl

Basic Information
Total Employees:
Purchase the Jm Sante Sp. z o.o. sp. k. report to view the information.
Outstanding Shares:
Purchase the Jm Sante Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
January 04, 2019
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Ownership Details
Purchase this report to view the information.
91.74%
Purchase this report to view the information.
2.75%
Purchase this report to view the information.
2.75%
Purchase this report to view the information.
2.75%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Jm Sante Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
108.89%▲
Total operating revenue
115.11%▲
Operating profit (EBIT)
-327.62%▼
Net Profit (Loss) for the Period
-344.25%▼
Total assets
619.78%▲
Total equity
-63.44%▼
Operating Profit Margin (ROS)
-6.01%▼
Net Profit Margin
-6.47%▼
Return on Equity (ROE)
-159.26%▼
Quick Ratio
-2.24%▼
Cash Ratio
-0.33%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo